Wealthspire Advisors, LLC Amgen Inc Transaction History

Wealthspire Advisors, LLC

$9.71 Billion
Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 8,669 shares of AMGN stock, worth $2.51 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,669

Previous 8,407 3.12%

Holding current value

$2.51 Million

Previous $2.63 Million 6.36%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $81,057 - $88,393	262 Added 3.12%	8,669 $2.79 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $27,063 - $32,888	-103 Reduced 1.21%	8,407 $2.63 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $109,430 - $132,095	-407 Reduced 4.56%	8,510 $2.42 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $49,861 - $56,249	-195 Reduced 2.14%	8,917 $2.57 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $1.16 Million - $1.45 Million	5,326 Added 140.68%	9,112 $2.45 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $89,993 - $106,415	-420 Reduced 9.99%	3,786 $840,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $408,002 - $497,286	-1,807 Reduced 30.05%	4,206 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $447,982 - $569,215	1,956 Added 48.21%	6,013 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $70,929 - $79,995	-316 Reduced 7.23%	4,057 $914,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $397,513 - $442,363	1,723 Added 65.02%	4,373 $1.06 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $702,321 - $776,951	-3,203 Reduced 54.72%	2,650 $641,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $147,767 - $169,106	743 Added 14.54%	5,853 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $693,061 - $812,005	3,265 Added 176.96%	5,110 $1.09 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2 Million - $2.22 Million	-8,571 Reduced 82.29%	1,845 $450,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $603,151 - $702,874	2,718 Added 35.31%	10,416 $2.59 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $625,121 - $744,408	2,889 Added 60.07%	7,698 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $74,853 - $83,243	319 Added 7.1%	4,809 $1.22 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.68 Million - $2.06 Million	-8,494 Reduced 65.42%	4,490 $1.06 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $1.98 Million - $2.62 Million	10,858 Added 510.72%	12,984 $2.63 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $89,496 - $115,033	473 Added 28.61%	2,126 $512,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $287,803 - $344,848	1,653 New	1,653 $320,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $84,828 - $95,619	-469 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $83,669 - $97,669	469 New	469 $91,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Amgen Inc Transaction History